Dr. Jerry Herbert Singer, MD

Dr. Singer practices at Jerry H Singer MD in Cape Coral, Florida.

Dr. Singer's NPI, 1376545665, was assigned on June 1, 2005. Dr. Singer graduated from New York University School of Medicine in 1980. Dr. Singer holds Florida license ME42500.

Dr. Singer's primary practice is Jerry H Singer MD, at 1419 SE 8th Ter, Cape Coral, FL 33990 in Lee County. The practice phone is (561) 333-1118.

Dr. Singer's primary practice is Jerry H Singer MD in Cape Coral, Florida. Dr. Singer is also affiliated with Wellington Regional Medical Center. The medical group on file is GenesisCare. Dmand AI also links Dr. Singer to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singer practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Singer's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Singer is board certified in urology by the American Board of Urology. Dmand AI has Dr. Singer's licenses on file in 2 states: Florida and New York.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, kidney cysts, kidney stone disease, prostate cancer, prostate inflammation or infection and testicular dysfunction among the conditions Dr. Singer treats.

CMS data shows 4,865 Medicare services from Dr. Singer across 19 procedure codes in 2024, for 743 Medicare patients. Medicare paid $229,477 for them. Every service was in an office.

CMS counts 743 Medicare patients who saw Dr. Singer in 2024. The largest group is 65 to 74, with 308 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Singer's median patient age at 72, with 18% women.

In 2024, Dr. Singer wrote 3,058 Medicare Part D claims for 903 patients. 94% of them were for generic drugs. CMS names the drug for 2,936 of them, across 30 drugs with 11 or more claims each, at $737,402 in total drug cost. In 2023, CMS named 3,030 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Singer for performance year 2024, reported individually. Dr. Singer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Singer.

CMS Open Payments shows 340 general payments to Dr. Singer from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Dendreon Pharmaceuticals LLC paid the most, $2,175.

Dmand AI lists 5 awards for Dr. Singer, most recently Best Doctors in 2017.

Dr. Singer graduated from New York University School of Medicine in 1980.

Dr. Singer is in network with 17 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.